Chemed Corporation

NYSE:CHE Rapport sur les actions

Capitalisation boursière : US$8.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Chemed Résultats passés

Passé contrôle des critères 6/6

Chemed has been growing earnings at an average annual rate of 2.4%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 3.7% per year. Chemed's return on equity is 24.9%, and it has net margins of 12.9%.

Informations clés

2.4%

Taux de croissance des bénéfices

4.1%

Taux de croissance du BPA

Healthcare Croissance de l'industrie8.5%
Taux de croissance des recettes3.7%
Rendement des fonds propres24.9%
Marge nette12.9%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Ventilation des recettes et des dépenses

Comment Chemed gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

NYSE:CHE Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 242,3363014130
31 Mar 242,2932834110
31 Dec 232,2642733950
30 Sep 232,2252453920
30 Jun 232,1872263760
31 Mar 232,1652403690
31 Dec 222,1352503590
30 Sep 222,1292623540
30 Jun 222,1412773590
31 Mar 222,1422673650
31 Dec 212,1392693670
30 Sep 212,1323083610
30 Jun 212,1213033610
31 Mar 212,0913293510
31 Dec 202,0803193300
30 Sep 202,0692713220
30 Jun 202,0212633110
31 Mar 201,9922312980
31 Dec 191,9392203060
30 Sep 191,8742092890
30 Jun 191,8372012790
31 Mar 191,8062052760
31 Dec 181,7832062710
30 Sep 181,7532062760
30 Jun 181,7271902750
31 Mar 181,7001132710
31 Dec 171,667982710
30 Sep 171,642762610
30 Jun 171,617672540
31 Mar 171,5921142490
31 Dec 161,5771092380
30 Sep 161,5721062400
30 Jun 161,5661082340
31 Mar 161,5571112330
31 Dec 151,5431102330
30 Sep 151,5241102290
30 Jun 151,4961062290
31 Mar 151,4751032240
31 Dec 141,456992200
30 Sep 141,425922160
30 Jun 141,408852110
31 Mar 141,405762100
31 Dec 131,413772130
30 Sep 131,433812090

Des revenus de qualité: CHE has high quality earnings.

Augmentation de la marge bénéficiaire: CHE's current net profit margins (12.9%) are higher than last year (10.4%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: CHE's earnings have grown by 2.4% per year over the past 5 years.

Accélération de la croissance: CHE's earnings growth over the past year (32.9%) exceeds its 5-year average (2.4% per year).

Bénéfices par rapport au secteur d'activité: CHE earnings growth over the past year (32.9%) exceeded the Healthcare industry 6%.

Rendement des fonds propres

ROE élevé: CHE's Return on Equity (24.9%) is considered high.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y